1-10 of 10
Jelena Bila
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 3 Study of Teclistamab (Tec) in Combination with Lenalidomide (Len) and Tec Alone Versus Len Alone in Newly Diagnosed Multiple Myeloma (NDMM) As Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT): Safety Run-in (SRI) Results from the Majestec-4/EMN30 Trial

Elena Zamagni, Tobias Silzle, Ivan Špička, Sabrin Tahri, Sarah Lonergan, Inger S. Nijhof, Antonietta Pia Falcone, Evangelos Terpos, Jakub Radocha, Roberto Mina, Guldane Cengiz Seval, Meral Beksac, Cesar Rodriguez, Marcelo C. Pasquini, Michel Delforge, Vania Hungria, Donna Reece, Philippe Moreau, Yael C. Cohen, Kihyun Kim, Dominik Dytfeld, Jiří Minařík, Irene Strassl, Jelena Bila, Martin Schreder, Janusz Krawczyk, Fredrik Schjesvold, Caroline Cicin-Sain, Christoph Driessen, Gordon Cook, Lugui Qiu, Gonzalo Martin Garate, Agoston Gyula Szabo, Roman Hájek, Marc S. Raab, Silvia Mangiacavalli, Hermann Einsele, Andrew Spencer, Mario Boccadoro, Helen Vassalou, Lixia Pei, Yingqi Shi, Maria Krevvata, Ryan Gruber, Caline Sakabedoyan, Margaret Cobb, Jagoda Jasielec, Himal Amin, Rachel Kobos, Pieter Sonneveld, Niels W.C.J. van de Donk
Journal: Blood
Blood (2024) 144 (Supplement 1): 494.
https://doi.org/10.1182/blood-2024-205608
Published: 2024
Journal Articles

Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-Lenalidomide-Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)

Efstathios Kastritis, Meral Beksac, Sorina Nicoleta Badelita, Eirini Katodritou, Jelena Bila, Emmanouil Spanoudakis, Guldane Cengiz Seval, Zorica Cvetkovic, Olivera Markovic, Selami Kocak Toprak, Dimitra Dalampira, Daniel Coriu, Zoi Bezirgiannidou, Mario Pirsic, Toni Valkovic, Iulia Ursuleac, Aleksandra Sretenovic, Angeliki Sevastoudi, Josip Batinic, Sinziana Barbu, Maria Roussou, Maria Gavriatopoulou, Evangelos Terpos, Meletios A. Dimopoulos
Journal: Blood
Blood (2023) 142 (Supplement 1): 4734.
https://doi.org/10.1182/blood-2023-179416
Published: 2023
Journal Articles

Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Overall Survival Results from the Phase 3 Apollo Study

Meletios A. Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksac, Eirini Katodritou, Philippe Moreau, Luca Baldini, Argiris Symeonidis, Jelena Bila, Albert Oriol, Maria-Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Tobias Kampfenkel, Weiping Liu, Michele Kosh, NamPhuong Tran, Robin Carson, Pieter Sonneveld
Journal: Blood
Blood (2022) 140 (Supplement 1): 7272–7274.
https://doi.org/10.1182/blood-2022-163483
Published: 2022
Journal Articles

MajesTEC-4 (EMN30): A Phase 3 Trial of Teclistamab + Lenalidomide Versus Lenalidomide Alone As Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma

Elena Zamagni, Mario Boccadoro, Andrew Spencer, Michel Delforge, Donna E. Reece, Agoston Gyula Szabo, Hermann Einsele, Evangelos Terpos, Fredrik Schjesvold, Jelena Bila, Christoph Driessen, Meral Beksac, Gordon Cook, Cesar Rodriguez, Lixia Pei, Yingqi Shi, Caline Sakabedoyan, Jagaoda Jasielec, Himal Amin, Rachel Kobos, Pieter Sonneveld, Niels WCJ Van De Donk
Journal: Blood
Blood (2022) 140 (Supplement 1): 7289–7291.
https://doi.org/10.1182/blood-2022-159756
Published: 2022
Journal Articles

Pomalidomide and Dexamethasone with or without Subcutaneous Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma: Updated Analysis of the Phase 3 Apollo Study

Pieter Sonneveld, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksac, Eirini Katodritou, Philippe Moreau, Luca Baldini, Argiris Symeonidis, Jelena Bila, Albert Oriol, Maria-Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Tobias Kampfenkel, Yanping Qiu, Himal Amin, Michele Kosh, NamPhuong Tran, Robin Carson, Meletios A. Dimopoulos
Journal: Blood
Blood (2021) 138 (Supplement 1): 2747.
https://doi.org/10.1182/blood-2021-146907
Published: 2021
Journal Articles

Apollo: Phase 3 Randomized Study of Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Meletios A. Dimopoulos, MD, Evangelos Terpos, MD PhD, Mario Boccadoro, Sosana Delimpasi, MD, Meral Beksac, MD, Eirini Katodritou, MD, Philippe Moreau, MD, Luca Baldini, MD PhD, Argiris Symeonidis, MD PhD, Jelena Bila, Albert Oriol, Maria-Victoria Mateos, MD PhD, Hermann Einsele, MD, Ioannis Orfanidis, Tahamtan Ahmadi, MD PhD, Jon Ukropec, PhD, Tobias Kampfenkel, MD, Jordan Schecter, Yanping Qiu, Himal Amin, Jessica Vermeulen, MD PhD, Robin Carson, MD BA, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-135874
Published: 2020
Journal Articles

Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability

Tilmann Bochtler, Ute Hegenbart, Friedrich W. Cremer, Christiane Heiss, Axel Benner, Dirk Hose, Marion Moos, Jelena Bila, Claus R. Bartram, Anthony D. Ho, Hartmut Goldschmidt, Anna Jauch, Stefan O. Schonland
Journal: Blood
Blood (2008) 111 (9): 4700–4705.
https://doi.org/10.1182/blood-2007-11-122101
Published: 2008
Journal Articles

Longer Duration of Thalidomide Monotherapy Results in Improved Outcome in Relapsed/Refractory Multiple Myeloma.

Marie von Lilienfeld-Toal, Corinna Hahn-Ast, Francesco Bertolini, Jelena Bila, Mathieu Boulin, Heather Oakervee, Teresa Cibeira, Gordon Cook, Anna Dmoszynska, Roland Fenk, Tommasina Guglielmelli, Hartmut Goldschmidt, Yukata Hattori, Bethan Myers, Massimo Offidani, Francesca Patriarca, Maria Teresa Petrucci, Massimo Pini, Miles Prince, Steve Schey, Pieter Sonneveld, Ibrahim Yakoub-Agha, Anders Waage, Axel Glasmacher
Journal: Blood
Blood (2007) 110 (11): 2725.
https://doi.org/10.1182/blood.V110.11.2725.2725
Published: 2007
Journal Articles

Multiple Myeloma: Global Expression Profiling (GEP) Indicates Upregulation of the Ribosomal Machinery in Hyperdiploid Clones.

Friedrich W. Cremer, John De Vos, Dirk Hose, Jean François Rossi, Carina Ittrich, Thierry Rème, Axel Benner, Eric Jourdan, Marc S. Raab, Jelena Bila, Ann-Cathrin Theil, Sunitha Jonnakuty, Coral del Val, Marion Moos, Hartmut Goldschmidt, Bernard Klein, Anna Jauch
Journal: Blood
Blood (2004) 104 (11): 1421.
https://doi.org/10.1182/blood.V104.11.1421.1421
Published: 2004
Journal Articles

A New Molecular Classification of Multiple Myeloma Using Gene Expression Profiling and Fluorescence In Situ Hybridisation as Predictor for Event Free Survival.

Dirk Hose, Jean-Francois Rossi, Carina Ittrich, John deVos, Axel Benner, Thierry Reme, Jelena Bila, Veronique Grau, Marc Raab, Philine Kaukel, Eric Jourdan, Marion Moos, Ann-Cathrin Theil, Anna Jauch, Hartmut Goldschmidt, Bernard Klein, Friedrich W. Cremer
Journal: Blood
Blood (2004) 104 (11): 73.
https://doi.org/10.1182/blood.V104.11.73.73
Published: 2004